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Technology development in the recent years has enabled that both prevention and 
treatment of life-threatening heart rhythm disorders are managed by implantable 
cardioverter-defibrillators. Clinical studies have confirmed the advantage of this type of 
therapy in the prevention of sudden cardiac death in the recent years, so the use of 
ICDs has became a clinical routine. Rarely functional disturbances of those devices could 
be seen as undetected malignant arrhythmias (undersensing) or false detection of a 
normal heart rhythm (oversensing).  
Patient N.S. aged 67 years was admitted to Cardiology Clinic, Clinical Center Niš 
because of inappropriate sequential therapy of implantable cardioverter-defibrillator 
(ICD) (12 shocks were delivered within 48 hours before admission). ICD pacemaker was 
implanted four years before the admission due to dilated cardiomyopathy (LVEF 25%). 
Based on a detailed analysis of the device’s parameters the rapid increase in ventricular 
lead impedance was established (it was > 3000Ω; and the normal range is 250-2000 Ω). 
It was found that oversensing was the cause of sequential shocks delivery with energy 
of 35 J. The damaged lead of the ICD detected false signals as VF (ventricular 
fibrillation) and applied therapy. On the third day of hospitalization, the patient received 
an ICD Medtronic Maximo II device with the active electrode Medtronic Sprint Quattro 
6947 but the left atrial electrode was not displaced. Prophylactic antibiotic therapy was 
given and patient was discharged 5 days after implantation. After one month at the 
control visit device parameters were satisfactory, the sensing function was appropriate 
with good impedance of the lead. Special feature of these devices is the need for 
individual programming, tailored to each patient, so it is necessary for a center that 
performs the implantation to have a medical team that has experience in the application 
of this type of therapy. Acta Medica Medianae 2013;52(4):44-47. 
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Introduction 
 
  Technology development in the recent 
years in the prevention and treatment of life- 
threatening heart rhythm disorders has been 
focused on implantable cardioverter-defibrillators. 
Clinical studies have confirmed the advantage of 
this type of therapy in the prevention of sudden 
cardiac death, which has become clinical routine 
in the recent years (1). There are well-defined 
and generally accepted indications for ICD therapy, 
both in the field of primary as well as secondary 
prevention. Implantation procedure is technically 
almost equal to those for the pacemakers for 
bradycardia treatment. Special feature of these 
devices is the need for individual programming, 
tailored to each patient, so it is necessary for a 
center that performs the implantation to have a 
medical  team that has experience in the 
application of this type of therapy (2). Significantly 
positive results of this type of therapy lead to its 
increased use even in the area of primary 
prevention, and further technological development 
will allow its use in more specific indication (3). 
  Patient N.S.,aged 67 years, was admitted 
to Cardiology Clinic, Clinical Center Niš because 
of inappropriate sequential therapy of an implan-
table cardioverter-defibrillator (ICD) (12 shocks 
delivered within 48 hours before admission). ICD 
was implanted 4 years before admission due to 
dilated cardiomyopathy (LVEF 25%). Coronary 
angiography was performed before device implan-
tation to exclude significant coronary artery 
disease. Based on 24 hour Holter (ECG) monitoring, 
which showed sinus node disease and pauses in 
heart rhythm up to 2.7 sec, it was decided to 
implant a two-chamber ICD pacemaker. After 
pacemaker implantation, the patient felt well and Acta Medica Medianae 2013, Vol.52(4)                                     Oversensing as a cause of inappropriate implantable cardioverter... 
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one year before admission to the hospital he had 
one treatment of ventricular tachycardia in form 
of antitachycardia ICD pacing. After admission to 
clinic, an ICD device control was immediately 
done and it was found that the patient in the 
previous 48 hours received 12 electrical shocks 
with energy of 35 J. Additional detailed analysis 
of other parameters established the rapid 
increase in ventricular lead impedance over 3000 
Ω (normal range is within 250-2000 Ω). It was 
determined that oversensing was the cause of 
repeated ICD discharge with electrical shocks of 
35 J (Figure 1). ICD lead due to damage detected 
false signals as VF (ventricular fibrillation) and 
applied therapy (Figure 2). Radiography of the 
whole system did not verify the lead fracture 
which is a common cause of signal oversensing 
due to the presence of the bone and connective 
tissue under the clavicle where electrodes usually 
pass. However, radiography sometimes cannot 
show damage of the isolation around the lead, 
which was probably in this case the cause of the 
increased impedance of the same. Therefore, the 
lead replacement was the only solution. Extrac-
tion i.e. removing of the old electrode after 4 
years of implantation requires special extractors 
(laser), which currently we do not have, so we 
decided to leave the old electrode inactive and to 
install the new one beside it. On the third day of 
hospitalization, the patient received new ICD 
Medtronic Maximo II pacemaker with the active 
electrode Medtronic Sprint Quattro 6947 and a 
new battery because the old one was running 
out. Left atrial electrode was not displaced (Figure 
3 and 4). Patient received prophylactic antibiotic 
therapy and was discharged 5 days after 
pacemaker implantation. After one month during 
the regular visit, the checked parameters of the 
device were satisfactory, the sensing function 
was adequate with good lead impedance. 
 
 
 
Figure 1. 
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Figure 3.                                                                          Figure 4. 
 
Discussion  
 
Tachyarrhythmia therapy is allocated on 
the basis of the interpretation of the signals 
presented to the generator (4). All current ICDs 
use ventricular heart rate as the cornerstone 
variable in tachycardia recognition. However, to 
determine heart rate, the interval between each 
depolarization of the ventricle must be measured. 
It is not interval recognition but the detection of 
individual electrogram events that become the 
basic building block in this process. The process 
begins with the placement of the sensing lead. 
The sensed electrogram depends on the health of 
the myocardium in close proximity to the lead, 
the far-field structures of the diaphragm and 
right atrium, and other electrical devices such as 
pacemakers, cellular phones, and other sources 
of electromagnetic interference. Detection of the 
ECG events completely depends on the quality of 
the signal, and the quality of the signal is deter-
mined only at the time of the lead placement. As 
defibrillation efficacy is almost always best at the 
right ventricular apex, the adequacy of sensing is 
sometimes compromised by the apical position of 
the lead. Additional aspects that potentially 
depend on the position of the lead are measures 
of ECG morphology such as electrogram event 
width. In dual chamber devices, the accurate 
recognition of arrhythmias is even more compli-
cated with the inclusion of atrial lead data input 
into the generator. No longer will placement of 
the lead minimize the chances of miscounting 
arrhythmias;  however,  the  atrial  lead  must  be 
positioned so that there is no discernible 
ventricular electrogram. Sensing is an issue not 
only of signal to noise ratio in the ventricle but 
also of the exclusion of all non-atrial events on 
the atrial lead.  
For many years, ICDs have been the 
treatment of choice for secondary prevention of 
VT or VF if the arrhythmia is likely to recur 
despite  other therapy (5). In the 21
st  century, 
most ICDs have been implanted for primary 
prevention in high risk patients who have not 
experienced VT or VF. Primary prevention guide-
lines identify high risk primarily by heart failure 
class >2 and LVEF<30-35%. At present, more 
than 80% of ICDs are implanted for primary 
prevention. Secondary prevention guidelines are 
supported by an overwhelming consensus of 
experts and practicing cardiologists (6). They 
have been widely adopted. In contrast, primary 
prevention guidelines are applied variably in 
clinical practice. Experts vary in their level of 
concern about comorbidities as contraindications, 
complications and the high number of patients 
who need to receive ICDs to save one life.  
ICD sensing and detection is imperfect: ICD 
detected VT or VF can represent either a tachy-
cardia SVT or VT or oversensing of non-
arrhythmic electrical signals. ICD also discriminate 
tachycardia imperfectly: true SVT episodes may 
be classified as VT or VF, and true VT may be 
classified as SVT. ICDs might also deliver un-
necessary shocks for VT that could be terminated 
by antitachycardia pacing. The first step is to 
determine if therapy was delivered in response to 
oversensing or tachycardia. 
Shocks occur in the absence of tachycardia 
because  nonarrhythmic physiologic or non-
physiologic signals are oversensed and detected 
as arrhythmias. Non-physiologic signals usually 
are extracardiac. Physiologic signals may be 
intracardiac (p, R, or T waves) or extracardiac 
(myopotentials). Oversensing accounts for approxi-
mately one third of inappropriate shocks in long 
term follow-up. Oversensing of physiological 
intracardiac signals results in two device-detected 
R waves for each cardiac cycle. P wave over-
sensing and R wave double counting occur as 
alternating cycle lengths (7). T wave oversensing 
occurs as alternating morphologies. P wave 
oversensing can occur if the distal coil of an 
integrated bipolar lead is too close to the 
tricuspid valve. R wave double counting occurs if 
the duration of the sensing electrogram exceeds 
the ventricular blanking period of 120 to 140ms. 
It causes all VTs to be detected in the VF zone so 
that no VT is treated with antitachycardia pacing, 
regardless of its cycle length. T wave oversensing 
often occurs in the setting of low amplitude R 
waves.  In addition to causing inappropriate 
detection, T wave oversensing can cause inappro-
priate inhibition of bradycardia pacing or delivery 
of antitachycardia pacing at the wrong rate (8). 
 
Conclusions 
 
Oversensing can rarely cause inappropriate 
ICD shock delivery. In case of poor signal 
detection, especially when it involves electrode Acta Medica Medianae 2013, Vol.52(4)                                     Oversensing as a cause of inappropriate implantable cardioverter... 
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malfunction, it is urgent to establish the cause 
and promptly resolve the problems due to the 
specificity of the system. Cardiac rhythm distur-
bance detection is a specific and fundamental 
function of an ICD. This detection is based on 
heart rhythm, frequency, but it also requires 
individual programming, tailored to every patient. 
In this way, continuous individual programming 
always adapts to the patients and their needs in 
order to reduce the number of defibrillations to 
an acceptable minimum but without compro-
mising the patients’ safety. 
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Tehnološki razvoj je omogućio da se poslednjih godina pažnja prevencije i terapije 
ugrožavajućih  poremećaja  srčanog  ritma  usmeri  ka  implantabilnim  kardioverter- 
defibrilatorima. Kliničkim studijama potvrđena  je prednost ove vrste terapije u prevenciji 
iznenadne  srčane  smrti  kod  bolesnika,  tako  da  se  poslednjih  godina  ova  vrsta terapije 
poveća do nivoa rutinske primene. Međutim, retko može doći do poremećaja funkcije ovih 
uređaja  u vidu loše detekcije-nedetekcije malignih poremećaja  ritma  (undersensing)  ili 
pogrešne detekcije normalnog ritma (oversensing). Bolesnik N.S., star 67 godina, primljen 
je na Kliniku za kardiologiju Kliničkog centra Niš zbog uzastopnih terapija implantabilnog 
kardioverter-defibrilatora (ICD) (12 isporučenih šokova unutar 48h do prijema). Pre četiri 
godine  ugrađen  je  ICD  zbog  dilatantne  kardiomiopatije (EF 25%). Na osnovu detaljne 
analize ostalih parametara ustanovljen je rapidan porast impedance ventrikularne elektrode 
na preko 3000Ω (normalne vrednosti od 250-2000 Ω). Ustanovljeno je da je oversenzing 
bio uzrok ponavljane terapije u vidu šokova od 35J, jer je ICD detektovao lažne signale 
usled oštećenja elektrode kao VF (ventrikularna fibrilacija) i primenio terapiju. Trećeg dana 
hospitalizacije  bolesniku  je  ugrađen  ICD  Maximo  II  Medtronik,  sa  aktivnom  elektrodom 
Sprint quattro 6947 Medtronik i ostavljenom atrijalnom elektrodom. Bolesnik je pokriven 
antibiotskom terapijom i otpušten pet dana nakon ugradnje. Na kontroli, nakon mesec 
dana,  parametri  su  bili  uredni,  senzing  funkcija  zadovoljavajuća,  sa  dobrim  otporima 
elektroda. Posebna specifičnost ovih aparata je potreba za individualnim programiranjem, 
praktično za svakog bolesnika, tako da je neophodno da centar u kome se ugradnja vrši 
bude dobro opremljen timom koji ima iskustvo u primeni ove vrste terapije. Acta Medica 
Medianae 2013;52(4):44-47. 
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